CVS Health (CVS) PT Raised to $130 at Tigress Financial Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Six killed in cyclone off India's eastern coast
- Rivian shares slip ahead of Thursday earnings release
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
CVS, Walmart and Walgreens ordered to pay $650.6 million to Ohio counties in opioid case
August 17, 2022 12:09 PM EDTBy Brendan Pierson and Dietrich Knauth
(Reuters) -Pharmacy operators CVS, Walmart and Walgreens must pay a combined $650.6 million to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled Wednesday.
The order by U.S. District Judge Dan Polster in Cleveland marks the first time pharmacy chains have been ordered to pay money in an opioid lawsuit. It comes after a jury last November concluded that the companies helped create a public nuisance in Lake and Trumbull counties by over-supplying addictive... More
CVS Health (CVS) PT Raised to $120 at Cowen
August 15, 2022 8:15 AM EDTCowen analyst Charles Rhyee raised the price target on CVS Health (NYSE: CVS) to $120.00 (from $119.00) while maintaining a Outperform rating.... More
CVS Health (CVS) PT Raised to $120 at Mizuho Securities
August 15, 2022 6:33 AM EDTMizuho Securities analyst Ann Hynes raised the price target on CVS Health (NYSE: CVS) to $120.00 (from $115.00) while maintaining a Buy rating.... More



